Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma

Volume: 8, Issue: 6, Pages: 945 - 952
Published: Jul 26, 2017
Abstract
Background: null There are limited treatment options available for patients with advanced pancreatic ductal adenocarcinoma (PDAC). We conducted a phase II study evaluating the efficacy and safety of capecitabine/oxaliplatin (CAPOX) in patients with locally advanced and metastatic PDAC treated in the first and second lines. null Methods: null Forty subjects with advanced PDAC and ECOG performance status ≥2 were enrolled. Treatment consisted of...
Paper Details
Title
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
Published Date
Jul 26, 2017
Volume
8
Issue
6
Pages
945 - 952
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.